Private equity’s public markets exits on the up, OMERs’ deal for Audax’s Gastro Health scores around $950mn EV, Thoma Bravo backs PDFTron

SPACs slow down while Gastro Health commands a mid-$900 million value.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this